Advances in Nuclear Medicine & Molecular Imaging 2024
Advances in Nuclear Medicine and Molecular Imaging features fourteen internationally renowned faculty experts discussing nuclear medicine’s latest trends and emerging procedures. Created from the Mid-Eastern Chapter of the Society of Nuclear Medicine and Molecular Imaging’s 52nd Annual Conference, this activity presents the impact of radiopharmaceuticals on imaging, cardiology, oncology and much more. Robust discussions of imaging tools, administration equipment, dosimetry and future applications are included, as well.
Topics
| Advances in Nuclear Medicine & Molecular Imaging | |
| Developing a PET-CT RB-82 Myocardial Imaging Program | Jason Jenkins, CNMT |
| Rb-82 PET Myocardial Blood Flow Imaging | Jason Jenkins, CNMT |
| Molecular Imaging With PET to Detect and Quantify Atherosclerotic Plaques | Abass Alavi, MD |
| Session 2: Dosimetry | |
| Dosimetry Basics | Carlos Uribe, PhD |
| Personalized dosimetry for Y90 TARE | Kevin Hirsch, MD |
| Advanced Dosimetry Including Use in the Theranostics Routine | Michael Morris, MD |
| Session 3: Oncologic Imaging | |
| Can Radiotracer Based Bone Scanning to Detect Metastasis Survive the Test of Time | Abass Alavi, MD |
| Lymphoma Staging and Response Assessment: Past, Present and Future | Bruce Cheson, MD |
| Recent Developments and Issues in Differentiated Thyroid Cancer | Douglas Van Nostrand, MD |
| PET/CT in Brain Tumors: Current and Potential Future Applications | Mohammed Gharavi, MD |
| Systemic Therapy in Advanced Prostate Cancer: The Evolving Landscape | Asit Paul, PhD |
| Session 4: Radiation Safety & SPECT-CT | |
| Radiation Safety in the Age of Theranostics | Jayashree Parekh, MD |
| Our Quest for Ultra Low Dose PET-CT Scanning: Experience and Implications | Eliot Siegel, MD |
| Panel Discussion | Multiple Faculty |
| Benefits of SPECT-CT | Gabriel Soudry, MD |
| Session 5: Future Applications | |
| Hype, Reality, and the Future Potential of AI in Nuclear Medicine | Eliot Siegel, MD |
| Current and Emerging Radiopharmaceuticals in Theranostics | Joseph Osborne, MD |
| Expanding the Practice of Lu177 Based Radiopharmaceutical Therapies From a Tertiary Care Hospital to the Community: Opportunities and Challenges | Giuseppe Esposito, MD |
| PET Imaging’s Impact on Medicine, Research and Future Options | Abass Alavi, MD |
